avidbio.com - Rasio total nilai perusahaan marang pendapatan CDMO

Logo perusahaan publik avidbio.com (CDMO)

Geopolitical instability and export restrictions create risks for Avid Bioservices, Inc. (CDMO) raw material supplies. The EV/Sales multiple on the current GURU.Markets platform chart illustrates valuation dynamics, where serves as the parameter's baseline value. Experienced management is effectively expanding production capacity, while financial stability is supported by steady biotech sector demand for protein production.

CDMO: Nilai perusahaan marang pendapatan Avid Bioservices Inc 04.07.2022 - 20.11.2026

Avid Bioservices Inc - rincian analitis lan metrik utama (CDMO)

Analisis wiwitan perusahaan:CDMO, avidbio.com
Barang unggulan Avid Bioservices, Inc

This indicator measures the total enterprise value, including debt and subtracting cash, relative to annual sales to determine the asset's market overvaluation. By analyzing the EV/Revenue ratio, an investor assesses the capitalization efficiency of the Avid Bioservices, Inc. (CDMO) service model, where the diversification of the client portfolio within the contract drug manufacturing sector mitigates risks and stabilizes the company's fundamental value.